Stocks

Why Currenc Group (CURR) Stock Skyrocketed 400% Today

Currenc Group (NASDAQ: CURR) stock experienced an incredible surge on Wednesday, climbing over 400% following the announcement of its cutting-edge…

Read More »

Quantum BioPharma Approved to Dual List on Upstream Global Trading App

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced it was approved to dual list its shares on the Upstream…

Read More »

Fubo Stock Triples on Disney Streaming Merger, Why YouTube Should Be Concerned

Fubo (NYSE: FUBO) stock skyrocketed over 250% on Monday after the sports streaming platform announced a groundbreaking deal to merge…

Read More »

Shark Tank’s Kevin O’Leary Wants to Buy TikTok, Here’s How You Can Invest Too

Kevin O’Leary, the “Shark Tank” investor affectionately known as “Mr. Wonderful,” has set his sights on TikTok. Amid growing national…

Read More »

Quantum BioPharma Buys $1 Million of Bitcoin and Other Crypto

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced that the company has purchased USD $1 million worth of Bitcoin…

Read More »

How This $4 Stock is Taking on Wall Street’s Big Banks with a $700 Million Lawsuit

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91), a small biopharmaceutical company with an $8 million market cap, has launched…

Read More »

Fed Cuts Rates, Stocks and Crypto Slide on Powell’s Hawkish Tone

On Wednesday, the Federal Reserve’s decision to cut interest rates by 25 basis points sent shockwaves through financial markets, with…

Read More »

4 Stocks Leading the Charge in the $20 Billion Race to Stop the Progression of Multiple Sclerosis

The multiple sclerosis (MS) treatment market, valued at over $20 billion annually, is experiencing a transformative phase. With no definitive…

Read More »

Why Alphabet’s New ‘Willow’ Chip is Being Hailed as a Major Quantum Computing Breakthrough

Alphabet (NASDAQ: GOOGL) stock surged 6% on Tuesday, driven by a significant quantum computing breakthrough announcement. The company unveiled “Willow,”…

Read More »

Safety Review Committee Recommends Quantum BioPharma Proceed with Second Cohort Dosing in Phase 1 Lucid-MS Clinical Trial

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91), a biopharmaceutical company dedicated to building a portfolio of innovative assets and…

Read More »
Back to top button